Biomaterial Database

Regulatory approaches to stimulate innovative renal replacement therapies. 2020

Fokko P Wieringa, and Murray I Sheldon, and Ana Hidalgo-Simon

Foundation imec Netherlands, Connected Health Solutions, Eindhoven, Netherlands. fokko.wieringa@imec.nl.

UI	MeSH Term	Description	Entries
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017582	Renal Replacement Therapy	Procedures which temporarily or permanently remedy insufficient cleansing of body fluids by the kidneys.	Kidney Replacement Therapy,Replacement Therapy, Kidney,Replacement Therapy, Renal,Therapy, Kidney Replacement,Therapy, Renal Replacement,Kidney Replacement Therapies,Renal Replacement Therapies,Replacement Therapies, Kidney,Replacement Therapies, Renal,Therapies, Kidney Replacement,Therapies, Renal Replacement
D051437	Renal Insufficiency	Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE.	Kidney Insufficiency,Kidney Failure,Renal Failure,Failure, Kidney,Failure, Renal,Failures, Kidney,Failures, Renal,Insufficiency, Kidney,Kidney Failures,Kidney Insufficiencies,Renal Failures,Renal Insufficiencies
D062069	Inventions	A novel composition, device, or process, independently conceived de novo or derived from a pre-existing model.	Technological Innovations,Innovation, Technological,Innovations, Technological,Invention,Technological Innovation
D033161	Government Regulation	Exercise of governmental authority to control conduct.	Government Regulation and Oversight,Government Regulations,Regulation, Government,Regulations, Government
D035703	Therapies, Investigational	Treatments which are undergoing clinical trials or for which there is insufficient evidence to determine their effects on health outcomes; coverage for such treatments is often denied by health insurers.	Investigational Therapies,Experimental Therapies,Innovative Therapies,Investigational Treatments,Experimental Therapy,Innovative Therapy,Investigational Therapy,Investigational Treatment,Therapies, Experimental,Therapies, Innovative,Therapy, Experimental,Therapy, Innovative,Therapy, Investigational,Treatment, Investigational,Treatments, Investigational

Related Publications

Fokko P Wieringa, and Murray I Sheldon, and Ana Hidalgo-Simon

A Technology Roadmap for Innovative Approaches to Kidney Replacement Therapies: A Catalyst for Change.

October 2019, Clinical journal of the American Society of Nephrology : CJASN,

Fokko P Wieringa, and Murray I Sheldon, and Ana Hidalgo-Simon

Pediatric renal supportive therapies: the changing face of pediatric renal replacement approaches.

April 2010, Current opinion in pediatrics,

Fokko P Wieringa, and Murray I Sheldon, and Ana Hidalgo-Simon

European regulatory perspectives for innovative therapies.

June 2008, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA,

Fokko P Wieringa, and Murray I Sheldon, and Ana Hidalgo-Simon

[Regulatory framework of innovative therapies : From bench to bedside].

July 2011, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz,

Fokko P Wieringa, and Murray I Sheldon, and Ana Hidalgo-Simon

Renal replacement therapies.

January 2000, Critical care clinics,

Fokko P Wieringa, and Murray I Sheldon, and Ana Hidalgo-Simon

Renal replacement therapies.

January 2011, Missouri medicine,

Fokko P Wieringa, and Murray I Sheldon, and Ana Hidalgo-Simon

Approaches to kidney replacement therapies-opportunities and challenges.

January 2022, Frontiers in cell and developmental biology,